1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow MT 21: new trials by email Literature Review of MT 21 trials Research Report on MT 21
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of the Efficacy and Tolerability of Pancrelipase Microtablet (MT) Capsules for the Treatment of Cystic Fibrosis-dependent Exocrine Pancreatic Insufficiency Pancrease MT 10.5, or MT 21, Placebo for Pancrease MT 10.5 or MT 21 - Exocrine Pancreatic Insufficiency, Steatorrhea | Phase 3 | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 40 | 2008-08-01 | 2014-05-09 |
Cystic Fibrosis (1) · Exocrine Pancreatic Insufficiency (1) · Malabsorption Syndromes (1) · Steatorrhea (1)
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (1)
Canada (1) · United States (1)